Table 1

Characteristics of experimental therapies

ProfitAcademicTotal
Experimental therapies 5147431257
Trial phase Profit Academic % of experimental therapies
I1341.4
I/II4613.7
II6156049.4
II/III1351.4
III37715942.6
IV4141.4
Cancer type Profit Academic % of experimental therapies
Breast cancer3410411.0
Gastrointestinal cancer656410.3
Genitourinary cancer20314127.4
Haematological malignancy51578.6
Lung cancer84399.8
Melanoma45245.5
Rare tumours3231427.5